Clinical trial
Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage…
NCT00114153 · University of Virginia, Other · Completed
Key facts
| NCT number | NCT00114153 |
|---|---|
| Title | Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer |
| Official title | Phase I Trial of Induction Paraplatin® and Xeloda® Followed by Concurrent Paraplatin and Xeloda With Intensity Modulated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | University of Virginia, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | capecitabine, carboplatin, conventional surgery, radiation therapy |
| Enrollment | 48 |
| Start date | Jun 1, 2003 |
| First posted | Jun 14, 2005 |
| Last update posted | Nov 26, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: